FDA grants approval to first antiviral oral pill for Covid-19
Today's approval demonstrates that Paxlovid has met the agency's rigorous standards for safety and effectiveness, and that it remains an important treatment option.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Today's approval demonstrates that Paxlovid has met the agency's rigorous standards for safety and effectiveness, and that it remains an important treatment option.
Some people continue to suffer from the underlying effects of COVID-19, which manifests in the form of poor health. People suffer from anxiety.
• Study subjects with cardiovascular disease who took a daily multivitamin saw the greatest improvement in cognition.
HQ Team May 24, 2023: Lower back pain, which is one of the main reasons for years lived with disability, will afflict 843.
HQ Team May 23, 2023: The FDA cleared Opiant Pharmaceuticals’ nasal spray to treat opioid overdose in adult and paediatric patients under the.
HQ Team May 22, 2023: A study to find solutions for treating two new variations of diabetes, type 4 and type 5, is.
HQ Team May 20, 2023: AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood.
HQ Team May 19, 2023: Indicators to slow, halt or reverse age-related loss of muscle mass and strength were found after a study.
Researchers say the hormone estrogen causes a molecular dysfunction by altering a cell’s DNA and causing the breast tissue to develop.
Pfizer suspends sale of 4 antibiotics in India as there are some deviations observed in the manufacturing process
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com